Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other analysts have also issued reports on ALLO. Oppenheimer initiated coverage on shares of Allogene Therapeutics in a research note on Thursday, August 8th. […]
More Stories
Banco Bradesco (NYSE:BBD) Reaches New 52-Week Low – Here’s Why
Banco Bradesco S.A. (NYSE:BBD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday...
Alexandria Real Estate Equities, Inc. (NYSE:ARE) Shares Sold by Teachers Retirement System of The State of Kentucky
Teachers Retirement System of The State of Kentucky cut its stake in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE...
Hagerty, Inc. (NYSE:HGTY) Sees Significant Drop in Short Interest
Hagerty, Inc. (NYSE:HGTY – Get Free Report) was the target of a large decline in short interest during the month...
Brokerages Set Rexford Industrial Realty, Inc. (NYSE:REXR) Target Price at $51.09
Shares of Rexford Industrial Realty, Inc. (NYSE:REXR – Get Free Report) have been given an average recommendation of “Hold” by...
**Funko, Inc. Elects Jason Harinstein as New Director**
On December 13, 2024, Funko, Inc. (NASDAQ: FNKO) announced the appointment of Jason Harinstein as a Class I director, following...
Barclays PLC Acquires 22,752 Shares of UGI Co. (NYSE:UGI)
Barclays PLC boosted its holdings in shares of UGI Co. (NYSE:UGI – Free Report) by 7.8% in the 3rd quarter,...